Efficacy and safety of anti-TNF therapy for ankylosing spondylitis: long-term results
Nature Clinical Practice Rheumatology 4, 334 (2008). Ver artigo completo
There’s more to life than everyday function: the challenge of measuring social role participation in ankylosing spondylitis
Nature Clinical Practice Rheumatology 5, 46 (2009). Authors: Aileen M Davis, Rosalind Wong, Elizabeth M Badley & Monique A Gignac Ver artigo completo
How regulatory T cells work
Nature Reviews Immunology 8, 523 (2008). Authors: Dario A. A. Vignali, Lauren W. Collison & Creg J. Workman Regulatory T (TReg) cells are essential for maintaining peripheral tolerance, preventing autoimmune diseases and limiting chronic inflammatory diseases. However, they also limit beneficial responses by suppressing sterilizing immunity and limiting antitumour immunity. Given that TReg cells can have [...]
Primary prevention of systemic lupus erythematosus
Nature Clinical Practice Rheumatology 4, 576 (2008). Authors: Andrea Doria & Chiara Briani Ver artigo completo
Infliximab therapy for patients with ankylosing spondylitis: on-demand or continuous treatment?
Nature Clinical Practice Rheumatology 4, 398 (2008). Author: Joachim Sieper Ver artigo completo
The molecular basis of pain and its clinical implications in rheumatology
Nature Clinical Practice Rheumatology 5, 28 (2009). Authors: Brendan Bingham, Seena K Ajit, David R Blake & Tarek A Samad Ver artigo completo
Adalimumab suppresses markers of structural damage in ankylosing spondylitis
Nature Clinical Practice Rheumatology 4, 622 (2008). Ver artigo completo2
Available therapeutic options following failure of a first anti-TNF agent
Nature Clinical Practice Rheumatology 5, 115 (2009). doi:10.1038/ncprheum1028 Alan J Silman Ver artigo completo
New NICE Guidelines To Help Thousands Of People With Rheumatoid Arthritis
Arthritis / Rheumatology News From Medical News Today Thousands of people with rheumatoid arthritis are set to benefit from a new guideline to be published this week. The National Institute for Health and Clinical Excellence (NICE) and the National Collaborating Centre for Chronic Conditions will issue a guideline to improve the management of rheumatoid arthritis in [...]
Intensified COBRA therapy induces remission in 90% of patients with early RA
Nature Clinical Practice Rheumatology 4, 564 (2008). Ver artigo completo